PRKCA is an excellent functional candidate for predisposition to MS, since the disease is believed to be the result of misdirected immune response by autoreactive T cells against myelin antigens [33], and protein kinase C (PKC) plays a critical role in signal transduction controlling T-lymphocyte activation. Here, PRRT2 is linked to myeloid sarcoma.